Clinical Trial Update: Albumin for Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating albumin for hepatocellular carcinoma and hypoproteinemia is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Hypoproteinemia

Drugs mentioned

• Albumin

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma, Hypoproteinemia | Phase 3 | Status: UNKNOWN